The earnings call presented a strong performance for ResMed in Q4 FY 2025, with significant achievements in revenue growth, gross margin expansion, and innovation investments. Despite potential challenges from competitive bidding and some market-specific issues, particularly in China, the overall sentiment of the call was positive.

Company Guidance

In the Q4 Fiscal Year 2025 earnings call, ResMed reported a robust 10% year-over-year revenue growth and a 230 basis points expansion in gross margin. Their free cash flow for the fiscal year reached $1.7 billion, allowing them to invest in research and development, SG&A, and pursue strategic acquisitions such as Somnoware and VirtuOx. ResMed's goal is to improve over 500 million lives by 2030, and they currently serve more than 154 million people globally. They also announced plans to increase their quarterly dividend and share repurchase activity for fiscal year 2026, demonstrating confidence in their strong financial performance. The company achieved an operating margin of 35% and a 22% increase in net income. ResMed is focused on operational excellence and leveraging AI and GenAI technologies to enhance their digital health solutions.

Strong Revenue Growth

ResMed achieved a 10% year-over-year reported revenue growth and a 9% increase in constant currency terms for Q4 FY 2025, reflecting positive contributions across their product and ReSupply portfolio.

Gross Margin Expansion

The company reported a gross margin of 61.4% for Q4, marking a 230 basis points year-over-year increase and a 150 basis points sequential improvement, driven by procurement, manufacturing, logistics efficiencies, and favorable foreign currency movements.

Free Cash Flow and Shareholder Returns

ResMed generated $1.7 billion in free cash flow for FY 2025 and returned over $610 million to shareholders through dividends and share repurchases. The Board authorized a 13% increase in the quarterly dividend for FY 2026.

Investment in Innovation

The company emphasized ongoing investment in R&D and AI technologies, including the integration of AI and GenAI into their digital products, and the launch of the AirSense 11 platform and new patient interface technologies.

Expansion in Digital Health Ecosystem

ResMed continues to build a global digital health ecosystem, with acquisitions like Somnoware, Ectosense, and VirtuOx supporting the acceleration of their ResMed 2030 strategy.

Resmed (RMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

RMD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 23, 2025	2026 (Q1)	2.52 / -	2.2	―	―	―
Jul 31, 2025	2025 (Q4)	2.55 / 2.55	2.08	22.60% (+0.47)
Apr 23, 2025	2025 (Q3)	2.38 / 2.37	2.13	11.27% (+0.24)
Jan 30, 2025	2025 (Q2)	2.32 / 2.43	1.88	29.26% (+0.55)
Oct 24, 2024	2025 (Q1)	2.05 / 2.20	1.64	34.15% (+0.56)
Aug 01, 2024	2024 (Q4)	2.08 / 2.08	1.6	30.00% (+0.48)
Apr 25, 2024	2024 (Q3)	1.93 / 2.13	1.68	26.79% (+0.45)
Jan 24, 2024	2024 (Q2)	1.78 / 1.88	1.66	13.25% (+0.22)
Oct 26, 2023	2024 (Q1)	1.62 / 1.64	1.51	8.61% (+0.13)
Aug 03, 2023	2023 (Q4)	1.68 / 1.60	1.49	7.38% (+0.11)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

RMD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$271.37	$278.62	+2.67%
Apr 23, 2025	$213.53	$235.10	+10.10%
Jan 30, 2025	$255.98	$234.65	-8.33%
Oct 24, 2024	$236.99	$253.86	+7.12%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Resmed (RMD) report earnings?

Resmed (RMD) is schdueled to report earning on Oct 23, 2025, After Close (Confirmed).

What is Resmed (RMD) earnings time?

Resmed (RMD) earnings time is at Oct 23, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is RMD EPS forecast?

RMD EPS forecast for the fiscal quarter 2026 (Q1) is 2.52.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing